Prospective Validation of AKI Prediction
Recruiting
Observational Study
Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 Days – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Adam C Dziorny · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this prospective observational study is to implement, deploy, and quantify accuracy of an existing Pediatric Early AKI Risk Score algorithm. The implementation will be facilitated using a Health Level 7 (HL7) Fast Healthcare Interoperability Resource (FHIR)-based architecture. Investigators will deploy this model and store results in a manner not viewable to the clinical team caring…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients admitted to the Pediatric Intensive Care Unit or Pediatric Cardiac Intensive Care Unit
* Age \> 30 days and \< 18 years
Exclusion Criteria:
* Discharged less than 12 hours after admission
* AKI at 12 hours of admission by KDIGO Serum Criteria
Contacts